- title: "Fitness effects of mutations to SARS-CoV-2 proteins"
  authors: "Jesse D. Bloom, Richard A. Neher"
  summary: In this work, we present an analysis of SARS-CoV-2 circulating variants to develop a [detailed map of functional tolerance to mutations of all SARS-CoV-2 target proteins](https://jbloomlab.github.io/SARS2-mut-fitness/) to inform the discovery of antivirals that avoid intrinsic resistance.  
  img: SARS-CoV-2-fitness-effects.png
  date: 2023-01-31
  programs: [ASAPPTGTTM, ASAPPNBTAE, ASAPPBBTAH, ASAPPITANL, ASAPPFWOJB] # TODO: Add any other SARS-CoV-2 programs
  projects: [Project 1]
  cores: []
  preprint:
    server: bioRxiv
    url: https://doi.org/10.1101/2023.01.30.526314
    license: "CC BY 4.0"
    date: 2023-01-31
  github: jbloomlab/SARS2-mut-fitness
  data: https://jbloomlab.github.io/SARS2-mut-fitness/
- title: "An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition"
  authors: "Gabriela Dias Noske, Yun Song, Rafaela Sachetto Fernandes, Rod Chalk, Haitem Elmassoudi, Lizb√© Koekemoer, C. David Owen, Tarick J. El-Baba, Carol V. Robinson, The COVID Moonshot Consortium, Glaucius Oliva, Andre Schutzer Godoy"
  summary: A 3.5A cryo-EM structure of the SARS-CoV-2 main viral protease (Mpro) provides critical details of the N-terminal cleavage event and how different antivirals shift populations toward monomer or dimer.
  img: mpro-solution-snapshot.png
  date: 2023-03-20
  programs: [ASAPPTGTTM]
  projects: [Project 2]
  cores: []
  preprint:
    server: bioRxiv
    url: https://doi.org/10.1101/2020.12.23.424149
    license: "CC-BY-NC-ND 4.0 International license"
  published:
    doi: 10.1038/s41467-023-37035-5
    journal: Nature Communications
    date: 2023-03-20
    volume: 14
    pages: 1545
    year: 2023
    pmcid: PMC10027274
  data: https://www.nature.com/articles/s41467-023-37035-5#data-availability
- title: "Turning high-throughput structural biology into predictive inhibitor design"
  authors: "Kadi L. Saar, William McCorkindale, Daren Fearon, Melissa Boby, Haim Barr, Amir Ben-Schmuel, The COVID Moonshot Consortium, Nir London, Frank von Delft, John D. Chodera, Alpha A. Lee"
  summary: We develop a machine learning framework that leverages high-throughput X-ray crystallography data to outperform ligand- or structure-based methods in predicting potent ligands, and use this approach to discover a noncovalent nonpeptidomimetic inhibitor with 120 nM antiviral efficacy.
  img: high-throughput-predictive-design.jpg
  date: 2022-09-19
  programs: [ASAPPTGTTM]
  projects: [Project 3]
  cores: [Biochemical Assay Core, Structural Biology Core]
  preprint:
    server: bioRxiv
    url: https://doi.org/10.1101/2021.10.15.464568
    license: "CC-BY-NC 4.0 International license"
  published:
    doi: 10.1073/pnas.2214168120
    journal: Proceedings of the National Academy of Sciences USA
    date: 2023-03-06
    volume: 120
    pages: e2214168120
    year: 2023
    pmcid: PMC10089178
  github: kadiliissaar/ligand_design_structural_biology
- title: "Accelerating antiviral drug discovery: lessons from COVID-19"
  authors: "Annette von Delft, Matthew D. Hall, Ann Kwong, Lisa A. Purcell, Kumar Singh Saikatendu, Uli Schmitz, John A. Tallarico, and Alpha Lee"
  summary: We present a broad industry and academic perspective on key stages in the small-molecule antiviral discovery process and present strategies that could accelerate future efforts.
  programs: []
  projects: [Overall]
  published:
    doi: 10.1038/s41573-023-00692-8
    journal: Nature Reviews Drug Discovery
    date: 2023-04-29
    year: 2023